A prospective randomized cotrolled study comparing EUS sonopsy CY(R) and 22G biopsy needles for EUS-guided fine-needle aspiration of solid pancreatic mass lesions

Phase 2

• Conditions: solid pancreatic mass lesions

• Registration Number: JPRN-UMIN000020668
• Lead Sponsor: Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-01-20
• Study Completion: 2018-12-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Not provided

Exclusion Criteria

Patients with Performance status 4 Patients who have risk of bleeding,or patients with platelet count less than fifty thousand/mm2 Patients with antithrombotic agent 2 agent or more Patients with pancreatic mass which we cannot detect by EUS Pregnant woman Patients less than 20 years old Patients who do not agree to participate in this study Patients who determined to be inappropriate

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The tissue collection rate in each group.

Secondary Outcome Measures

Name	Time	Method
The tissue collection rate based on the tumor size location and puncture route, the tissue collection rate of all session , the tissue diagnosis rate and adverse event in each group.